Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells
- PMID: 10072520
Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells
Abstract
Lymphocyte activation gene-3 (LAG-3) is an MHC class II ligand structurally and genetically related to CD4. Although its expression is restricted to activated T cells and NK cells, the functions of LAG-3 remain to be elucidated. Here, we report on the expression and function of LAG-3 on proinflammatory bystander T cells that are activated in the absence of TCR engagement. LAG-3 is expressed at high levels on human T cells cocultured with autologous monocytes and IL-2 and synergizes with the low levels of CD40 ligand (CD40L) expressed on these cells to trigger TNF-alpha and IL-12 production by monocytes. Indeed, anti-LAG-3 mAb inhibits both IL-12 and IFN-gamma production in IL-2-stimulated cocultures of T cells and autologous monocytes. Soluble LAG-3Ig fusion protein markedly enhances IL-12 production by monocytes stimulated with infra-optimal concentrations of sCD40L, whereas it directly stimulates monocyte-derived dendritic cells (DC) for the production of TNF-alpha and IL-12, unravelling an enhanced responsiveness to MHC class II engagemenent in DC as compared with activated monocytes. Thus similar to CD40L, LAG-3 may be involved in the proinflammatory activity of cytokine-activated bystander T cells and most importantly it may directly activate DC.
Similar articles
-
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).J Immunol. 2002 Apr 15;168(8):3874-80. doi: 10.4049/jimmunol.168.8.3874. J Immunol. 2002. PMID: 11937541
-
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.Eur J Cancer. 2001 Sep;37(13):1709-18. doi: 10.1016/s0959-8049(01)00184-8. Eur J Cancer. 2001. PMID: 11527700
-
Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.J Immunol. 2008 Mar 15;180(6):3782-8. doi: 10.4049/jimmunol.180.6.3782. J Immunol. 2008. PMID: 18322184
-
LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination.Trends Immunol. 2003 Dec;24(12):619-22. doi: 10.1016/j.it.2003.10.001. Trends Immunol. 2003. PMID: 14644131 Review.
-
LAG-3 in Cancer Immunotherapy.Curr Top Microbiol Immunol. 2011;344:269-78. doi: 10.1007/82_2010_114. Curr Top Microbiol Immunol. 2011. PMID: 21086108 Free PMC article. Review.
Cited by
-
Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review.Front Oncol. 2024 Aug 26;14:1402837. doi: 10.3389/fonc.2024.1402837. eCollection 2024. Front Oncol. 2024. PMID: 39252941 Free PMC article. Review.
-
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.Signal Transduct Target Ther. 2020 Jul 29;5(1):134. doi: 10.1038/s41392-020-00256-x. Signal Transduct Target Ther. 2020. PMID: 32728035 Free PMC article. Review.
-
The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction.Arthritis Res. 2002;4 Suppl 3(Suppl 3):S169-76. doi: 10.1186/ar558. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110136 Free PMC article. Review.
-
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?Cancers (Basel). 2022 Mar 28;14(7):1710. doi: 10.3390/cancers14071710. Cancers (Basel). 2022. PMID: 35406483 Free PMC article. Review.
-
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer.Cancers (Basel). 2019 Aug 20;11(8):1213. doi: 10.3390/cancers11081213. Cancers (Basel). 2019. PMID: 31434339 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials